跳至主要内容
临床试验/ACTRN12620001267943
ACTRN12620001267943终止4 期

A randomised trial to assess the impact of midodrine on early mobilisation after total hip arthroplasty

Sir Charles Gairdner and Osborne Park Hospital Group0 个研究点目标入组 42 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults, aged > 18 years old
  • Elective unilateral total hip arthroplasty under spinal anaesthesia
  • Mentally competent to provide informed own written consent in English

排除标准

  • Spinal anaesthesia not planned, or refused by patient
  • Chronic renal impairment
  • Creatinine >2mg/dL or 180micmol/L
  • Clinical evidence of liver failure
  • Heart failure
  • NYHA class 3 or 4
  • Ejection fraction < 30%
  • Revision hip arthroplasty
  • Hip resurfacing surgery
  • Significant preoperative neuromuscular condition limiting mobility
  • Preoperative haemoglobin concentration < 110g/L
  • Prior diagnosis of postural hypotension
  • Patients taking digoxin
  • Pregnant/Lactating Women
  • Thyrotoxicosis
  • Pheochromocytoma
  • Allergy to Midodrine
  • Chronic urinary retention
  • Significant neuromuscular condition limiting mobility
  • Co-Enrolment in another vasopressor clinical trial

研究者

发起方
Sir Charles Gairdner and Osborne Park Hospital Group

相似试验